Results 111 to 120 of about 4,836 (184)

Comparative Effectiveness and Safety of Risankizumab vs Ustekinumab in Crohn's Disease: A Real-World Retrospective Cohort Study from Taiwan. [PDF]

J Inflamm Res
Meng MJ, Lin SH, Chen CM, Chen TD, Kuo CJ, Kou T, Chiu CT, Le PH.   +7 more
europepmc   +1 more source

Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade. [PDF]

eGastroenterology
Honap S, Colwill M, Dignass A, Jairath V, Magro F, Danese S, Peyrin-Biroulet L.   +6 more
europepmc   +1 more source

Adjusted Comparative Treatment Persistence of IL-23p19 Versus IL-17 Pathway Inhibitors in Adults With Plaque Psoriasis: A Systematic Review and Exploratory Meta-analysis of Real-World Time-to-Discontinuation Estimates. [PDF]

Cureus
Migdady DS, Alshyyab N, Alkhalaileh HM, Goh ZY, Reingold Y, Rababah O, Zghayer TM, Alsalhi Y, Alsaidi AK, Alrabbai MG.   +9 more
europepmc   +1 more source

Risankizumab (Skyrizi) [PDF]

Dermatologie pro praxi, 2020
openaire   +1 more source

Comparative Efficacy of Interleukin Inhibitors and JAK Inhibitors in Moderate to Severe Plaque Psoriasis. [PDF]

Cureus
Daily A, Danchulis L, Krulikowski K, Shectman B, Riskin SI.   +4 more
europepmc   +1 more source

Comparative effectiveness and safety of risankizumab vs ustekinumab in patients with Crohn's disease: a propensity score-matched multicenter retrospective cohort study. [PDF]

Crohns Colitis 360
Sawaf B, Battistin U, Abu-Rumaileh M, Gerges KM, Hallak Y, Abbarh S, Batikh E, Hadaki N, Elhadi M, Regueiro M, Al-Haddad M.   +10 more
europepmc   +1 more source

New drug: Risankizumab for psoriasis

Australian Prescriber, 2020
openaire   +3 more sources

Editorial: Risankizumab in Refractory Crohn's Disease-From Real-World Effectiveness to Strategic Positioning and Early Monitoring. [PDF]

Aliment Pharmacol Ther
Ernest-Suárez K, Hoentjen F.
europepmc   +1 more source

Real-World Treatment Patterns, Healthcare Resource Utilisation, and Costs in Biologic-Naïve Patients with Moderate-to-Severe Psoriasis Treated with Biologics in France. [PDF]

Dermatol Ther (Heidelb)
Passeron T, Ta R, Hospital V, Betts KA, Catillon M, Plays C, Jullien D.   +6 more
europepmc   +1 more source

Pharmacokinetics of IL-23p19 Inhibitors: A Systematic Review Across Immune-Mediated Inflammatory Diseases. [PDF]

Clin Pharmacokinet
Pool IA, de Groot ADE, Keizer RJ, Dubinsky MC, Torres J, Atreya R, Malik P, Dreesen E, Dijkstra G, Verkade HJ, Mian P, Bourgonje AR.   +11 more
europepmc   +1 more source